Latest Insider Transactions at Compass Therapeutics, Inc. (CMPX)
This section provides a real-time view of insider transactions for Compass Therapeutics, Inc. (CMPX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Compass Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Compass Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 08
2024
|
Vered Bisker Leib CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
49,198
-1.55%
|
$49,198
$1.45 P/Share
|
|
Feb 08
2024
|
Thomas J. Schuetz PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
44,782
-0.68%
|
$44,782
$1.45 P/Share
|
|
Jan 09
2024
|
Thomas J. Schuetz PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
637,500
+8.79%
|
$637,500
$1.93 P/Share
|
|
Jan 09
2024
|
Vered Bisker Leib CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,753,125
+35.58%
|
$1,753,125
$1.93 P/Share
|
|
Nov 17
2023
|
Vered Bisker Leib CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
64,415
-4.34%
|
$64,415
$1.5 P/Share
|
|
Nov 17
2023
|
Thomas J. Schuetz PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
44,025
-0.73%
|
$44,025
$1.5 P/Share
|
|
Mar 10
2023
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
10,000
+0.17%
|
$30,000
$3.37 P/Share
|
|
Feb 27
2023
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.33%
|
$60,000
$3.98 P/Share
|
|
Feb 15
2023
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.33%
|
$60,000
$3.86 P/Share
|
|
Feb 08
2023
|
Thomas J. Schuetz PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+7.73%
|
-
|
|
Feb 08
2023
|
Vered Bisker Leib CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+21.22%
|
-
|
|
Jan 31
2023
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.36%
|
$80,000
$4.05 P/Share
|
|
Jan 24
2023
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.37%
|
$80,000
$4.19 P/Share
|
|
Nov 25
2022
|
Vered Bisker Leib CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2
-0.0%
|
$8
$4.36 P/Share
|
|
Nov 23
2022
|
Vered Bisker Leib CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
9,569
-0.89%
|
$38,276
$4.3 P/Share
|
|
Nov 22
2022
|
Vered Bisker Leib CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
14,929
-1.38%
|
$59,716
$4.19 P/Share
|
|
Nov 21
2022
|
Vered Bisker Leib CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
16,035
-1.46%
|
$64,140
$4.34 P/Share
|
|
Nov 18
2022
|
Vered Bisker Leib CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
6,226
-0.56%
|
$24,904
$4.4 P/Share
|
|
Nov 08
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
402,000
+2.57%
|
$1,206,000
$3.21 P/Share
|
|
Nov 08
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
402,000
+2.57%
|
$1,206,000
$3.21 P/Share
|
|
Sep 28
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
10,000
+0.18%
|
$20,000
$2.32 P/Share
|
|
Sep 26
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
15,000
+0.28%
|
$30,000
$2.27 P/Share
|
|
Sep 07
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
15,000
+0.28%
|
$45,000
$3.03 P/Share
|
|
Sep 01
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
15,000
+0.28%
|
$30,000
$2.83 P/Share
|
|
Aug 17
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
15,000
+0.28%
|
$45,000
$3.05 P/Share
|
|
Aug 10
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
15,000
+0.28%
|
$30,000
$2.64 P/Share
|
|
Aug 01
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
15,000
+0.28%
|
$30,000
$2.58 P/Share
|
|
Jun 21
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.37%
|
$40,000
$2.8 P/Share
|
|
Jun 16
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.38%
|
$40,000
$2.34 P/Share
|
|
Jun 13
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
30,000
+0.56%
|
$60,000
$2.29 P/Share
|
|
Jun 06
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
30,000
+0.57%
|
$60,000
$2.83 P/Share
|
|
Jun 01
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.38%
|
$60,000
$3.03 P/Share
|
|
May 26
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.38%
|
$60,000
$3.04 P/Share
|
|
May 23
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
18,355
+0.35%
|
$36,710
$2.72 P/Share
|
|
May 17
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,215
+0.39%
|
$40,430
$2.47 P/Share
|
|
May 13
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
30,722
+0.21%
|
$61,444
$2.49 P/Share
|
|
May 13
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
30,722
+0.21%
|
$61,444
$2.49 P/Share
|
|
May 12
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
97,094
+0.65%
|
$194,188
$2.35 P/Share
|
|
May 12
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
97,094
+0.65%
|
$194,188
$2.35 P/Share
|
|
May 11
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
64,700
+0.44%
|
$64,700
$1.79 P/Share
|
|
May 11
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
64,700
+0.44%
|
$64,700
$1.79 P/Share
|
|
May 10
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
27,836
+0.54%
|
$27,836
$1.8 P/Share
|
|
May 10
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
24,447
+0.17%
|
$24,447
$1.6 P/Share
|
|
May 10
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
24,447
+0.17%
|
$24,447
$1.6 P/Share
|
|
May 09
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
90,712
+0.62%
|
$90,712
$1.56 P/Share
|
|
May 09
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
90,712
+0.62%
|
$90,712
$1.56 P/Share
|
|
May 06
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
10,200
+0.07%
|
$10,200
$1.63 P/Share
|
|
May 06
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
10,200
+0.07%
|
$10,200
$1.63 P/Share
|
|
Nov 16
2021
|
Vered Bisker Leib CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
600,000
+35.02%
|
-
|
|
Nov 16
2021
|
Thomas J. Schuetz PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
600,000
+10.48%
|
-
|